Attached files
| file | filename |
|---|---|
| 10-K - 10-K - Predictive Oncology Inc. | v214104_10k.htm |
| EX-3.2 - Predictive Oncology Inc. | v214104_ex3-2.htm |
| EX-3.1 - Predictive Oncology Inc. | v214104_ex3-1.htm |
| EX-32.1 - EX-32.1 - Predictive Oncology Inc. | v214104_ex32-1.htm |
| EX-31.2 - EX-31.2 - Predictive Oncology Inc. | v214104_ex31-2.htm |
| EX-31.1 - EX-31.1 - Predictive Oncology Inc. | v214104_ex31-1.htm |
| EX-14.1 - Predictive Oncology Inc. | v214104_ex14-1.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement No. 333-155299 of BioDrain Medical, Inc. (the Company) on Form S-1/A and on Form S-8 of our report, dated March 31, 2011, which expresses an unqualified opinion and includes an explanatory paragraph relating to the Company’s ability to continue as a going concern, appearing in this Annual Report on Form 10-K of BioDrain Medical, Inc. for the year ended December 31, 2010.
Olsen Thielen & Co., Ltd.
St. Paul, Minnesota
March 31, 2011